COL4A5 and Alport syndrome: While 90% of subjects with conventional Alport syndrome experience end-stage renal disease (ESRD) by the age of 30 years, approximately half of patients with the COL4A5 c.1871G>A variant still do not require dialysis in their fifties, and only a quarter of male carriers of this allele suffer from hearing loss [127].